-+ 0.00%
-+ 0.00%
-+ 0.00%

Daxor Announces Transition To Securities Exchange Act Of 1934 Reporting Company

Benzinga·02/10/2026 13:06:13
Listen to the news

"The strategic decision to transition back to Exchange Act reporting is a financial validation of our focused growth strategy," said Robert Michel, Daxor's Chief Financial Officer. "Daxor has achieved the scale necessary to align our regulatory and operational frameworks with our identity as a high-growth medical diagnostic company, enhancing transparency and comparability for our investors."